Stocks and Investing Stocks and Investing
Tue, July 20, 2021

Danielle Antalffy Maintained (ABT) at Hold with Increased Target to $128 on, Jul 20th, 2021


Published on 2024-10-27 17:15:12 - WOPRAI, Danielle Antalffy
  Print publication without navigation


Danielle Antalffy of SVB Leerink, Maintained "Abbott Laboratories" (ABT) at Hold with Increased Target from $115 to $128 on, Jul 20th, 2021.

Danielle has made no other calls on ABT in the last 4 months.



There are 11 other peers that have a rating on ABT. Out of the 11 peers that are also analyzing ABT, 1 agrees with Danielle's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • James Mainwaring of "Atlantic Equities" Initiated at Hold and Held Target at $122 on, Thursday, April 15th, 2021


These are the ratings of the 10 analyists that currently disagree with Danielle


  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $135 on, Monday, July 12th, 2021
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $125 on, Friday, June 4th, 2021
  • Travis Steed of "Barclays" Maintained at Buy with Decreased Target to $125 on, Wednesday, June 2nd, 2021
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $120 on, Wednesday, June 2nd, 2021
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $126 on, Wednesday, June 2nd, 2021
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $116 on, Wednesday, June 2nd, 2021
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Wednesday, June 2nd, 2021
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Decreased Target to $127 on, Tuesday, June 1st, 2021
  • Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, June 1st, 2021
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $140 on, Wednesday, April 21st, 2021
Contributing Sources